Difference between revisions of "Parkin"
(New page: {{Subst:infobox}}) |
m |
||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Parkin.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 9: | Line 8: | ||
|- | |- | ||
| Synonyms | | Synonyms | ||
| − | | | + | | Ubiquitin E3 ligase PRKN |
|- | |- | ||
| Determination type | | Determination type | ||
| − | | In | + | | In vitro |
|- | |- | ||
| Source | | Source | ||
| Line 18: | Line 17: | ||
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| − | | | + | | Cytosol |
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| − | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/O60260 O60260 ] |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | | + | | - |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| − | | | + | | [[TG2 reactive residues (Parkin)|K49]] |
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| − | | | + | | VIFAG''K''ELRND |
|- | |- | ||
| Structure | | Structure | ||
| − | | [http://www.rcsb.org/pdb/explore/explore.do?structureId= | + | | [http://www.rcsb.org/pdb/explore/explore.do?structureId=1IYF 1IYF] |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| Line 42: | Line 41: | ||
|- | |- | ||
| Reference | | Reference | ||
| − | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=15132984&dopt=Abstract PMID:15132984] |
|- | |- | ||
| Notes | | Notes | ||
| − | | | + | | |
| + | |- | ||
| + | |Video | ||
| + | |{{#ev:dailymotion|7ebyfxNw2r8XekXX0|300}} | ||
| + | |- | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:50, 10 March 2015
| Parkin | |
|---|---|
| |
| Substrate peptide name | Parkin |
| Synonyms | Ubiquitin E3 ligase PRKN |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | O60260 |
| Reactive glutamines | - |
| Reactive lysines | K49 |
| Substrate sequence | VIFAGKELRND |
| Structure | 1IYF |
| Surface accessibility | ASAView pdf |
| Disorder prediction | IUPred |
| Reference | PMID:15132984 |
| Notes | |
| Video | 7ebyfxNw2r8XekXX0|300}} |
